Some studies concluded that matriptase mRNA levels were not significantly increased in breast cancer compared to in normal breast tissue, but other studies reported that high matriptase expression is predictive of poor survival for breast cancer as assessed by immunohistochemistry [20, 21]. This evidence concerns the gene ST14 and breast carcinoma.